A detailed history of Generali Asset Management Spa Sgr transactions in Biogen Inc. stock. As of the latest transaction made, Generali Asset Management Spa Sgr holds 16,195 shares of BIIB stock, worth $2.31 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
16,195
Holding current value
$2.31 Million
% of portfolio
0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$146.47 - $191.55 $2.37 Million - $3.1 Million
16,195 New
16,195 $2.48 Billion

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Generali Asset Management Spa Sgr Portfolio

Follow Generali Asset Management Spa Sgr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Generali Asset Management Spa Sgr, based on Form 13F filings with the SEC.

News

Stay updated on Generali Asset Management Spa Sgr with notifications on news.